Each of our companies started off small: two people, a vision and determination to change the way healthcare worked. At IMS, it was creating information about healthcare activity that never existed before. For Quintiles, it was introducing data science to drug development.
We continue to have bold ambitions.
Technology solutions to power your competitive differentiation and accelerate your business model transformation
Our clinical and commercial
Our DataThe world’s largest and most diverse set of healthcare information, including privacy protected, anonymized patient level data to provide granularity
Our PeopleAn uncommon blend of clinical, commercial, data and technology experts all working together to create solutions that cut across disciplines
Over the past decade, there has been a paradigm shift in the treatment of cancer, driven by advances in personalized medicine and immuno-oncology. In this report, we share our perspective on some of the trends observed in 2016, including impact on cancer outcomes, the redefinition of many cancers, availability and costs of oncology therapeutics and complexity in cancer treatments.
We cannot just claim to bring clinical, commercial and real-world insights together because we put them into one company. We have to make it happen. And it is by connecting our capabilities in new ways throughout the product lifecycle that we do.